Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01629823 · ClinicalTrials.gov registry record · NA
Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP)
A NA study, sponsored by American Lung Association Asthma Clinical Research Centers.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT01629823: Completed NA study, sponsored by American Lung Association Asthma Clinical Research Centers.
NCT01629823 is a NA study that has completed, run by American Lung Association Asthma Clinical Research Centers. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01629823, a NA study, has completed, sponsored by American Lung Association Asthma Clinical Research Centers.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
The CPAP trial is a 3-arm parallel design randomized sham-controlled trial. Participants are randomly assigned in equal allocation to one of three treatments: CPAP 10 cm water (H₂O) (high) vs. CPAP 5 cm H₂O (medium) vs. CPAP Sham (less than 1 cm H₂O, Low). The treatment period is 12 weeks with airways reactivity assessed at baseline, 6 and 12 weeks of treatment and after a 2 week washout.
Interventions
- DEVICE Continuous Positive Airway Pressure device (Resmed, Swift, Mirage)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01629823
The ClinicalTrials.gov registry entry for NCT01629823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Lung Association Asthma Clinical Research Centers, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Positive Airway Pressure device (Resmed, Swift, Mirage) is the first listed.
NCT01629823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01629823 about?
NCT01629823 is a clinical study titled "Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP)". The CPAP trial is a 3-arm parallel design randomized sham-controlled trial. Participants are randomly assigned in equal allocation to one of three treatments: CPAP 10 cm water (H₂O) (high) vs. CPAP 5 cm H₂O (medium) vs. CPAP Sham (less than 1 cm H₂O, Low). The treatment period is 12 weeks with airwa...
What is the current status of trial NCT01629823?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2012-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01629823?
The interventions under investigation include: Continuous Positive Airway Pressure device (Resmed, Swift, Mirage) (DEVICE).
Who is sponsoring clinical trial NCT01629823?
This trial is sponsored by American Lung Association Asthma Clinical Research Centers, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.